Skip to main content

Clive Kelly ORCID iD

This author is included in the Autistic Autism Scholarship Project because of their contribution to two academic works co-authored with two people identified as autistic.

Learn more about how autistic status is determined

Publication overview

Autistic Autism Scholarship Project publications

Number of publications in the project: 2
Number of publications with a cited bibliography: 2
Number of publications with an identified autistic co-author: 2

Collaborations and cited bibliographies

Number of publication co-authors identified as autistic: 2 (distinct: 2)
Number of cited references with an identified autistic author: 26
Number of cited authors identified as autistic: 41 (distinct: 27)

Publications by year

1
2024
1
2026

Publication types

Journal article 2

2 publications

Filters

Sort and display
Clear

Clive Kelly, James Leonard Downs*Autistic author. Learn more… (2026). Seeing Each Other Clearly: A Dual Perspective on Providing Healthcare to Neurodivergent People. British Journal of Healthcare and Medical Research, 13(01), 359-371.

Publication date: 24 Feb 2026 Added to AutiHub: 29 Oct 2026 Type: Journal article Language: English
Publication authors identified as autistic: 1 / 2 (50.0%) Cited references with an identified autistic author: 17 / 63 (27.0%) Cited author occurrences identified as autistic: 27 / 300 (9.0%) Distinct cited authors identified as autistic: 19 / 269 (7.1%)

Clive Kelly, Ren Martin, Rachael Taylor, Mary Doherty*Autistic author. Learn more… (2024). Recognising and responding to physical and mental health issues in neurodivergent girls and women. British Journal of Hospital Medicine, 85(4), 1-12.

Publication date: 2 Apr 2024 Added to AutiHub: 5 Jul 2026 Type: Journal article Language: English
Publication authors identified as autistic: 1 / 4 (25.0%) Cited references with an identified autistic author: 9 / 39 (23.1%) Cited author occurrences identified as autistic: 14 / 397 (3.5%) Distinct cited authors identified as autistic: 13 / 360 (3.6%)